Your browser doesn't support javascript.
loading
Pertuzumab Plus Trastuzumab in Patients With Endometrial Cancer With ERBB2/3 Amplification, Overexpression, or Mutation: Results From the TAPUR Study.
Ahn, Eugene R; Rothe, Michael; Mangat, Pam K; Garrett-Mayer, Elizabeth; Ali-Ahmad, Hussein M; Chan, John; Maitland, Michael L; Patel, Sapna R; Reese, Zachary; Balmanoukian, Ani S; Drescher, Charles W; Li, Rui; Tsimberidou, Apostolia M; Leath, Charles A; O'Lone, Raegan; Grantham, Gina N; Halabi, Susan; Schilsky, Richard L.
Afiliação
  • Ahn ER; Cancer Treatment Centers of America-Chicago, part of City of Hope, Zion, IL.
  • Rothe M; American Society of Clinical Oncology, Alexandria, VA.
  • Mangat PK; American Society of Clinical Oncology, Alexandria, VA.
  • Garrett-Mayer E; American Society of Clinical Oncology, Alexandria, VA.
  • Ali-Ahmad HM; Michigan Cancer Research Consortium, Lansing, MI.
  • Chan J; Sutter Cancer Research Consortium, San Francisco, CA.
  • Maitland ML; Inova Schar Cancer Institute, Fairfax, VA.
  • Patel SR; University of Virginia Comprehensive Cancer Center, Charlottesville, VA.
  • Reese Z; Cancer Research Consortium of West Michigan, St Joseph, MI.
  • Balmanoukian AS; Intermountain Healthcare, Murray, UT.
  • Drescher CW; The Angeles Clinic and Research Institute, A Cedars-Sinai Affiliate, Los Angeles, CA.
  • Li R; Swedish Cancer Institute, Seattle, WA.
  • Tsimberidou AM; Providence Cancer Institute, Providence Portland Medical Center, Portland, OR.
  • Leath CA; The University of Texas MD Anderson Cancer Center, Houston, TX.
  • O'Lone R; O'Neal Comprehensive Cancer Center at the University of Alabama at Birmingham School of Medicine, Birmingham, AL.
  • Grantham GN; American Society of Clinical Oncology, Alexandria, VA.
  • Halabi S; American Society of Clinical Oncology, Alexandria, VA.
  • Schilsky RL; Duke University Medical Center, Durham, NC.
JCO Precis Oncol ; 7: e2200609, 2023 04.
Article em En | MEDLINE | ID: mdl-37027810

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Neoplasias do Endométrio Idioma: En Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Israel

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Neoplasias do Endométrio Idioma: En Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Israel